0
Allogene Therapeutics, Inc. Banner Image

Allogene Therapeutics, Inc. has reached its limit for free report views

Work for Allogene Therapeutics, Inc.? Upgrade Your Profile and unlock all your responsibility reports.

Allogene Therapeutics, Inc.

  • Ticker ALLO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Allogene Therapeutics, Inc. Logo Image
  • 201-500 Employees
  • Based in South San Francisco, California
Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. Led by a management team with significant experience in cell therapy, Allogene is developing a pipeline of “off-the-shelf” CAR T cell therapy candidates with the goal of deliveringMore readily available cell therapy on-demand, more reliably, and at greater scale to more patients.
REPORT RATINGS
4.8 / 5.0 (138)

Allogene Therapeutics, Inc. reports have an aggregate usefulness score of 4.8 based on 138 reviews.

Allogene Therapeutics, Inc.

Most Recent Responsibility Report

Allogene Therapeutics, Inc.
MOST RECENT 2022 Environmental, Social & Governance Report

Report Locked. Allogene Therapeutics, Inc. has reached its limit for free report views.

Allogene Therapeutics, Inc. does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.

Request Information
Our service enables potential investors to review the most recent and archived Allogene Therapeutics, Inc. Sustainability Report, Allogene Therapeutics, Inc. Corporate Social Responsibility Report, Allogene Therapeutics, Inc. CSR Report, Allogene Therapeutics, Inc. Corporate Responsibility, Allogene Therapeutics, Inc. CR Report, Allogene Therapeutics, Inc. Citizenship Report, Allogene Therapeutics, Inc. ESG Report, and Allogene Therapeutics, Inc. Environmental Report online.
Allogene Therapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!